IgVH and Other High-Risk Cytogenetic Risk Factors in CLL
A review of the cytogenetic risk factors that help to determine frontline therapy for patients with newly diagnosed chronic lymphocytic leukemia (CLL). For more ...
Targeted Oncology
Treatment for Cytogenetic-related Outcomes in CLL
OncLiveTV
Causes and Consequences of Genetic Abnormalities in Chronic Lymphocytic Leukemia
March 23, 2010: Matthew P. Strout, M.D., Ph.D.
Yale Cancer Center
Cell-intrinsic biomarkers in CLL: focus on cytogenetics
Chronic lymphocytic leukemia (CLL) patients with a complex karyotype have poorer outcomes than those without these features; further analysis of these ...
VJHemOnc – Video Journal of Hematological Oncology
Why aren’t cytogenetic analyses being implemented into clinical studies of CLL?
Panagiotis Baliakas, MD, PhD, from Uppsala University, Uppsala, Sweden, explains the reasons why cytogenetic analyses are seldom performed in clinical ...
VJHemOnc – Video Journal of Hematological Oncology
Cytogenetics, TP53 and immunoglobulin genes: exciting areas of research for CLL
Kostas Stamatopoulos, MD, PhD, from The Centre for Research & Technology, Thermi, Greece, talks to us about the importance of networking with laboratories ...
VJHemOnc – Video Journal of Hematological Oncology
Lymphocytic leukemia-associated chromosomal abnormalities - Video abstract: 18669
Video abstract of review paper "Chronic lymphocytic leukemia-associated chromosomal abnormalities and miRNA deregulation" published in open access ...
Dove Medical Press
R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
Earn CME: https://naccme.com/program/7330 In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates ...
ImedexCME
Advances in Blood Cancers: Living with Chronic Lymphocytic Leukemia (CLL) - Treatment
Learn about the factors used to determine when to begin treatment, current and emerging therapies, and the role of clinical trials in the treatment of chronic ...
Leukemia & Lymphoma Society
Advances in Blood Cancers: Living with Chronic Lymphocytic Leukemia (CLL) - Diagnosis
Learn about the symptoms and diagnosis of chronic lymphocytic leukemia (CLL). Video features Jennifer Brown, MD, PhD and Jeffrey Hellman, PA-C of ...
Leukemia & Lymphoma Society
Novel Treatment Options in CLL
Earn CME: https://naccme.com/program/7330 In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates ...
ImedexCME
Histopathology - CLL/SLL - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - Proliferation centres - Prolymphocytes, paraimmunoblasts - CD5+, CD23+ Slides for the ...
Filip Sokol
Use of Novel Prognostic Markers in Practice for CLL
Earn CME: https://www.naccme.com/oln © 2020 Imedex, an HMP Company.
ImedexCME
Diagnosis: Morphology, Flow Cytometry, Cytogenetics, Molecular Testing, and Risk-Stratification
Experts discuss how to diagnosis AML. Faculty: AnneMarie W. Block, PhD, FACMG Director, Clinical Cytogenetics Laboratory Division of Diagnostic Hematology ...
American Society of Hematology
New Advances in Therapies for Chronic Lymphocytic Leukemia CLL
Dr. Parameswaran Venugopal from Rush University Medical Center delivered this presentation at the Leukemia Research Foundation Treatment Options for ...
Leukemia Research Foundation
Chronic Lymphocytic Leukaemia (CLL) Education Presentation
Lymphoma Australia, alongside Janssen, were pleased to host a special live webinar event about chronic lymphocytic leukaemia (CLL). Our guest speakers ...
Lymphoma Australia
What Testing is Done Alongside a Diagnosis of CLL?
With regard to cytogenetic testing, molecular testing, and imaging, Nicole Lamanna, M.D., outlines what testing should be completed alongside a diagnosis of ...
curetoday
Role of chemotherapy in CLL management
In this presentation from Lymphoma & Myeloma 2016, Dr. Bruce D. Cheson discusses the role of chemotherapy in the management of chronic lymphocytic ...
ImedexCME
Case 1: Newly Diagnosed CLL, IGHV-Unmutated
The panel comments on prognostic markers in chronic lymphocytic leukemia and genetic risk assessment. For more resources and information regarding ...
Targeted Oncology
The Ongoing Role Transplant in Chronic Lymphocytic Leukemia
In this segment, Jennifer Brown, MD, PhD; William Wierda, MD, PhD; and Javier Pinilla-Ibarz, MD, PhD, explain the role of hematopoietic stem cell transplant as ...
OncLiveTV
Dr. Kahl on the Impact of Venetoclax in Chronic Lymphocytic Leukemia
Brad Kahl, MD, professor in the Department of Medicine, Washington University School of Medicine in St. Louis, Siteman Cancer Center, discusses the impact of ...
OncLiveTV
Novel Btk Inhibitor Heads to Phase III Trials in Chronic Lymphocytic Leukemia
An experimental oral drug given once a day is drawing responses from about 70% of patients with relapsed chronic lymphocytic leukemia. Dr. Susan O'Brien ...
MDedge: news and insights for busy physicians
Dr. Awan on the Importance of FISH Testing in CLL
Farrukh Awan, MBBS, associate professor, The Ohio State University Comprehensive Cancer Center, discusses the importance of Fluorescence in situ ...
OncLiveTV
Minimal Residual Disease in Chronic Lymphocytic Leukemia
In this segment, Jennifer Brown, MD, PhD; Javier Pinilla-Ibarz, MD, PhD; and William Wierda, MD, PhD, assess the value minimal residual disease in the ...
OncLiveTV
Are complex karyotypes reliable prognostic markers for CLL?
Panagiotis Baliakas, MD, PhD, from Uppsala University, Uppsala, Sweden, presents the results from a multi-institutional study conducted at the European ...
VJHemOnc – Video Journal of Hematological Oncology
The role of karyotyping in CLL
Highlights of iwCLL 2017 - Karyotyping in CLL by Dr Davide Rossi.
Lymphoma Hub
Approaching a Case of Chronic Lymphocytic Leukemia
Key opinion leader William G. Wierda, MD, PhD, breaks down the case of a 78-year-old woman who presents with a case of chronic lymphocytic leukemia.
Targeted Oncology
Treating Younger and Older Individuals with Chronic Lymphocytic Leukemia
In this segment, Javier Pinilla-Ibarz, MD, PhD; William Wierda, MD, PhD; and Jennifer Brown, MD, PhD, describe various treatment options for younger and older ...
OncLiveTV
Diagnosis and treatment of newly diagnosed ALL
Earn CME: https://naccme.com/program/7310 In this presentation from the 'New and Emerging Agents in ALL and the Evolving Treatment Paradigm' symposium, ...
ImedexCME
Advances in the molecular stratification of chronic lymphocytic leukemia
Anna Schuh, MD, PhD, from the University of Oxford, UK, gives an overview of her talk on the advances in the molecular stratification of chronic lymphocytic ...
VJHemOnc – Video Journal of Hematological Oncology
Targeting Molecular and Genetic Abnormalities in CLL
Filmed on location in Barcelona, Spain during the 11th European Congress on Hematologic Malignancies, this webcast is part of a series that provides ...
ImedexCME
Clinical Objectives in Chronic Lymphocytic Leukemia Treatment
The panelists, William G. Wierda, MD, PhD; Susan M. O'Brien, MD; Thomas J. Kipps, MD, PhD; and Richard R. Furman, MD, discuss clinical objectives that help ...
OncLiveTV
CHC 2018: DR. Graeme Fraser - Chronic Lymphocytic Leukemia (CLL)
Dr. Graeme Fraser (Juravinski Cancer Centre) updates the CARE Hematology Faculty on updates in both front-line and relapsed CLL management, framed from ...
CARE Education
CLL: Managed Care Outlook on Clinical Trial Data
John Fox, MD, MHA, reviews the clinical significance of the data behind treatment of patients with high-risk versus low-risk cytogenetics and the follow-up data of ...
AJMCtv
Chronic Lymphocytic Leukemia | Dr. Tony Talebi discusses "What is CLL?" with Dr. Rosenblatt.
Dr. Tony Talebi discusses "What is Chronic Lymphocytic Leukemia?" with Dr. Rosenblatt. For further discussion visit http://www.HemOnc101.com. Dr. Tony ...
Tony
CLL treatment New Options, More Hope
In this webcast, Dr. Versha Banerji discusses diagnosis and approach to CLL management, the indications to treat and the decision making based on patient ...
The Leukemia & Lymphoma Society of Canada
Novel agents in the pipeline for CLL & lymphoma
In this presentation from Lymphoma & Myeloma 2016, Dr. Swaminathan P. Iyer discusses novel agents in the pipleine for the treatment of chronic lymphocytic ...
ImedexCME
CLL - Then and Now
Hello, my name is Emili Montserrat. I'm from the University of Barcelona in Spain and it is my pleasure to share with you some key slides of my presentation on ...
Oncology.TV
Identifying predictive markers for CLL
John Seymour, MD, MPH from the Peter MacCallum Cancer Center, Melbourne, Australia, discusses predictive markers for chronic lymphocytic leukemia (CLL) ...
VJHemOnc – Video Journal of Hematological Oncology
Combining B-cell receptor antagonists and venetoclax in CLL
Richard Furman, MD, of the Weill Cornell Medical College, New York, NY, outlines the benefit of combining B-cell receptor antagonist and venetoclax to provide ...
VJHemOnc – Video Journal of Hematological Oncology
Lymphoma - What is the role of diagnostic testing/cytogenetics in 2016
Andrew Zelenetz, MD, PhD, Vice Chair Medical Informatics, Department of Medicine and Medical Director, Memorial Sloan Kettering Cancer Center, talks with ...
GRACE - Global Resource for Advancing Cancer Education
CLL Biology
Lymphoma Canada presents Dr. Nathalie Johnson, Physician, Division of Hematology, Jewish General Hospital as she discusses the Changing Landscape of ...
LymphomaTV
